Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Cited by
Items 701–800 of 1,008
Funck‐Brentano, E., Alvarez, J., Longvert, C., Abé, E., Beauchet, A., Funck‐Brentano, C., & Saïag, P. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv189 · Cited by 55
Chedik, L., Bruyère, A., Vée, M. L., Stieger, B., Denizot, C., Parmentier, Y., Potin, S., & Fardel, O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169480 · Cited by 56
Bioavailability of Flavonoids: The Role of Cell Membrane Transporters
Čvorović, J., Žiberna, L., Fornasaro, S., Tramer, F., & Passamonti, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813006-3.00022-2 · Cited by 59
Schlessinger, A., Welch, M. A., van Vlijmen, H., Korzekwa, K., Swaan, P. W., & Matsson, P. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1174 · Cited by 56
Self-citationAnion Exchange Drives Reversible Phase Transfer of Coordination Cages and Their Cargoes
Grommet, A. B., Hoffman, J. B., Percástegui, E. G., Mosquera, J., Howe, D. J., Bolliger, J. L., & Nitschke, J. R. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b07900 · Cited by 55
Impact of Osmotically Active Excipients on Bioavailability and Bioequivalence of BCS Class III Drugs
Chen, M., Sadrieh, N. K., & Yu, L. X. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9509-z · Cited by 55
Komazawa, H., Yamaguchi, H., Hidaka, K., Ogura, J., Kobayashi, M., & Iseki, K. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23433 · Cited by 55
Sweeney, Z. K., Fu, J., & Wiedmann, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500223x · Cited by 55
Clinical Pharmacokinetics and Pharmacodynamics
Grover, A., & Benet, L. Z. (2013) · CRC Press eBooks · doi:10.1081/e-ept4-120050213 · Cited by 55
Self-citationHsiao, Y., Su, B., & Tseng, Y. J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa160 · Cited by 56
Structural basis of promiscuous substrate transport by Organic Cation Transporter 1
Zeng, Y. C., Sobti, M., Quinn, A., Smith, N. J., Brown, S. H. J., Vandenberg, J. I., Ryan, R. M., O’Mara, M. L., & Stewart, A. G. (2023) · Nature Communications · doi:10.1038/s41467-023-42086-9 · Cited by 54
Fenner, K. S., Jones, H. M., Ullah, M., Kempshall, S., Dickins, M., Lai, Y., Morgan, P., & Barton, H. A. (2012) · Xenobiotica · doi:10.3109/00498254.2011.626464 · Cited by 53
Shingaki, T., Takashima, T., Ijuin, R., Zhang, X., Onoue, T., Katayama, Y., Okauchi, T., Hayashinaka, E., Cui, Y., Wada, Y., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206425 · Cited by 58
Self-citationPreclinicalin vivoADME studies in drug development: a critical review
Pellegatti, M. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.652084 · Cited by 54
Clinical disposition, metabolism andin vitrodrug–drug interaction properties of omadacycline
Flarakos, J., Du, Y., Gu, H., Wang, L., Einolf, H. J., Chun, D. Y., Zhu, B. Y., Alexander, N., Natrillo, A., Hanna, I. H., et al. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1213465 · Cited by 54
Pan, Y., Hsu, V., Grimstein, M., Zhang, L., Arya, V., Sinha, V. P., Grillo, J. A., & Zhao, P. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.740 · Cited by 56
Self-citationYoshikado, T., Toshimoto, K., Nakada, T., Ikejiri, K., Kusuhara, H., Maeda, K., & Sugiyama, Y. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074823 · Cited by 54
Self-citationVectorizing agrochemicals: enhancing bioavailability via carrier‐mediated transport
Wu, H., Xu, H., Marivingt‐Mounir, C., Bonnemain, J., & Chollet, J. (2018) · Pest Management Science · doi:10.1002/ps.5298 · Cited by 54
Mapping the perturbome network of cellular perturbations
Caldera, M., Müller, F., Kaltenbrunner, I., Licciardello, M. P., Lardeau, C.-H., Kubicek, S., & Menche, J. (2019) · Nature Communications · doi:10.1038/s41467-019-13058-9 · Cited by 56
Kabeya, T., Mima, S., Imakura, Y., Miyashita, T., Ogura, I., Yamada, T., Yasujima, T., Yuasa, H., Iwao, T., & Matsunaga, T. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.04.334 · Cited by 60
Lei, Z., Teng, Q., Wu, Z., Ping, F., Song, P. K., Wurpel, J. N. D., & Chen, Z. (2021) · MedComm · doi:10.1002/mco2.106 · Cited by 56
Pharmacogenetics of Membrane Transporters: A Review of Current Approaches
Sissung, T. M., Goey, A. K. L., Ley, A. M., Strope, J. D., & Figg, W. D. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0956-8_6 · Cited by 56
De Bruyn, T., Ufuk, A., Cantrill, C., Kosa, R. E., Bi, Y.-A., Niosi, M., Modi, S., Rodrigues, A. D., Tremaine, L. M., Varma, M. V. S., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081315 · Cited by 53
Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems
Roghani, A. K., Garcia, R. I., Roghani, A., Reddy, A. P., Khemka, S., Reddy, R. P., Pattoor, V., Jacob, M., Reddy, P. H., & Sehar, U. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102291 · Cited by 57
Sharma, P. K., Butters, C., Smith, V., Elsby, R., & Surry, D. D. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.003 · Cited by 61
Liu, X.-J., Zou, L., Liu, F., Zhou, Y., & Song, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070896 · Cited by 54
Expression of indocyanine green-related transporters in hepatocellular carcinoma
Shibasaki, Y., Sakaguchi, T., Hiraide, T., Morita, Y., Suzuki, A., Baba, S., Setou, M., & Konno, H. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.07.055 · Cited by 53
Strategies to optimize the brain availability of central nervous system drug candidates
Wager, T. T., Villalobos, A., Verhoest, P. R., Hou, X., & Shaffer, C. L. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.564158 · Cited by 52
Uchida, Y., Ohtsuki, S., Kamiie, J., Ohmine, K., Iwase, R., & Terasaki, T. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.11.002 · Cited by 57
Iwao, T., Kodama, N., Kondo, Y., Kabeya, T., Nakamura, K., Horikawa, T., Niwa, T., Kurose, K., & Matsunaga, T. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062604 · Cited by 54
Challenges in the Development of Functional Assays of Membrane Proteins
Tiefenauer, L., & Demarche, S. F. (2012) · Materials · doi:10.3390/ma5112205 · Cited by 60
Ge, S., Yin, T., Xu, B., Gao, S., & Hu, M. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1812-1 · Cited by 54
Mogalian, E., German, P., Kearney, B. P., Yang, C. Y., Brainard, D. M., Mcnally, J. J., Moorehead, L., & Mathias, A. A. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0334-7 · Cited by 53
Kotsampasakou, E., & Ecker, G. F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00518 · Cited by 56
Beig, A., Fine‐Shamir, N., Porat, D., Lindley, D., Miller, J. M., & Dahan, A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.09.012 · Cited by 54
Amino Acid Transporters as Disease Modifiers and Drug Targets
Bröer, S. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218755629 · Cited by 58
Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
Lozano, E., Briz, Ó., Macías, R. I. R., Serrano, M. A., Marín, J. J. G., & Herráez, E. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8020014 · Cited by 53
Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics
Cronin-Fenton, D. P., & Damkier, P. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2018.03.001 · Cited by 42
Huang, J., Wen, C., Zhao, G., Dai, Y., Li, Y., Wu, L., & Zhou, H. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3603-y · Cited by 56
Super-resolution Surface-Enhanced Raman Scattering Imaging of Single Particles in Cells
de Albuquerque, C. D. L., & Schultz, Z. D. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01864 · Cited by 54
Wiebe, S. T., Gießmann, T., Hohl, K., Schmidt‐Gerets, S., Hauel, E., Jambrecina, A., Bader, K., Ishiguro, N., Taub, M. E., Sharma, A., et al. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00907-w · Cited by 53
Exploiting user models and context-awareness to support personal daily activities
Cheverst, K., & Byun, H. E. (2001) · Lancaster EPrints (Lancaster University) · Cited by 53
Molecular basis for selective uptake and elimination of organic anions in the kidney by OAT1
Parker, J. L., Kato, T., Kuteyi, G., Sitsel, O., & Newstead, S. L. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01039-y · Cited by 52
Assessment of gadoxetate DCE‐MRI as a biomarker of hepatobiliary transporter inhibition
Ulloa, J. L., Stahl, S. H., Yates, J. W. T., Woodhouse, N., Kenna, J. G., Jones, H. B., Waterton, J. C., & Hockings, P. D. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2946 · Cited by 57
Yin, J., Duan, H., Shirasaka, Y., Prasad, B., & Wang, J. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066175 · Cited by 52
Iwai, M., Minematsu, T., Li, Q., Iwatsubo, T., & Usui, T. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040733 · Cited by 55
Glaeser, H., Bujok, K., Schmidt, I., Fromm, M. F., & Mandery, K. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1000-6 · Cited by 52
A Screening Study of Drug–Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel
Floyd, J. S., Kaspera, R., Marciante, K. D., Weiss, N. S., Heckbert, S. R., Lumley, T., Wiggins, K. L., Tamraz, B., Kwok, P.-Y., Totah, R. A., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.295 · Cited by 56
Cheng, Z., Liu, H., Yu, N., Wang, F., An, G., Xu, Y. C., Liu, Q., Guan, C., & Ayrton, A. D. (2012) · Xenobiotica · doi:10.3109/00498254.2012.675455 · Cited by 57
Zhou, T., Hu, M., Cost, M. R., Poloyac, S. M., & Rohan, L. C. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0032 · Cited by 52
Jin, L., Kikuchi, R., Saji, T., Kusuhara, H., & Sugiyama, Y. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187161 · Cited by 52
Self-citationFluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line
Caetano-Pinto, P., Janssen, M. J., Gijzen, L., Verscheijden, L. F. M., Wilmer, M. J. G., & Masereeuw, R. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00821 · Cited by 58
Wu, J., Lin, N., Li, F., Zhang, G., He, S., Zhu, Y., Ou, R., Li, N., Liu, S., Feng, L., et al. (2016) · Scientific Reports · doi:10.1038/srep25343 · Cited by 52
El‐Kattan, A. F., & Varma, M. V. S. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.080044 · Cited by 54
Harwood, M. D., Zhang, M., Pathak, S. M., & Neuhoff, S. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086959 · Cited by 53
Glutamine transporters as pharmacological targets: From function to drug design
Scalise, M., Pochini, L., Galluccio, M., Console, L., & Indiveri, C. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.02.005 · Cited by 57
Clinical relevance of drug efflux pumps in the gut
Misaka, S., Müller, F., & Fromm, M. F. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.010 · Cited by 53
Reese, M. J., Bowers, G. D., Humphreys, J. E., Gould, E. P., Ford, S. L., Webster, L. O., & Polli, J. W. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1081993 · Cited by 51
Self-citationWesterhout, J., Smeets, J. M. W., Danhof, M., & de Lange, E. C. M. (2013) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-013-9314-4 · Cited by 53
Epigenetic Regulation of Organic Anion Transporting Polypeptide 1B3 in Cancer Cell Lines
Imai, S., Kikuchi, R., Tsuruya, Y., Naoi, S., Nishida, S., Kusuhara, H., & Sugiyama, Y. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1117-1 · Cited by 51
Self-citationThermosensitive Liposomes for the Delivery of Gemcitabine and Oxaliplatin to Tumors
May, J. P., Ernsting, M. J., Undzys, E., & Li, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400321e · Cited by 51
Sugimoto, H., Hirabayashi, H., Kimura, Y., Furuta, A., Amano, N., & Moriwaki, T. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035774 · Cited by 56
Lundquist, P., Englund, G., Skogastierna, C., Lööf, J., Johansson, J., Hoogstraate, J. A., Afzelius, L., & Andersson, T. B. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054528 · Cited by 51
Vishwanathan, K., Mair, S. J., Gupta, A., Atherton, J., Clarkson-Jones, J. A., Edeki, T. I., & Das, S. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055335 · Cited by 51
Wu, X., Ma, J., Ye, Y., & Lin, G. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.11.024 · Cited by 52
Mahnke, H., Ballent, M., Baumann, S., Imperiale, F. A., von Bergen�, M., Lanusse, C., Lifschitz, A., Honscha, W., & Halwachs, S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068940 · Cited by 51
The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology
Yu, H. M., Hasan, N. M., In, J. G., Estes, M. K., Kovbasnjuk, O. N., Zachos, N. C., & Donowitz, M. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105211 · Cited by 53
Drug-drug interactions of non-vitamin K oral anticoagulants
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1225037 · Cited by 56
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing.
Yang, Y., Qiu, J., Li, Y., Di, J., Zhang, W., Jiang, Q., Zheng, D.-W., Chen, Y., Wei, M.-N., Huang, J.-R., et al. (2016) · PubMed · Cited by 62
Lee, W., Ha, J.-M., & Sugiyama, Y. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.009132 · Cited by 49
Self-citationDeorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies
Yee, S. W., Buitrago, D., Stecula, A., Ngo, H. X., Chien, H., Zou, L., Koleske, M. L., & Giacomini, K. M. (2020) · The FASEB Journal · doi:10.1096/fj.202001497r · Cited by 49
Self-citationIshiguro, N., Kishimoto, W., Volz, A., Ludwig-Schwellinger, E., Ebner, T., & Schaefer, O. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053561 · Cited by 51
Fruit/Vegetable-Drug Interactions: Effects on Drug Metabolizing Enzymes and Drug Transporters
Rodríguez‐Fragoso, L., & Reyes-Esparz, J. (2013) · InTech eBooks · doi:10.5772/48283 · Cited by 56
Scheer, N., & Wolf, C. R. (2014) · Xenobiotica · doi:10.3109/00498254.2013.815831 · Cited by 49
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride
Metry, M., Shu, Y., Abrahamsson, B., Cristofoletti, R., Dressman, J., Groot, D. W., Parr, A. F., Langguth, P., Shah, V. P., Tajiri, T., et al. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.01.011 · Cited by 54
Self-citationInhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters
Brake, L. H. M. T., Rüssel, F. G. M., van den Heuvel, J. J. M. W., de Knegt, G. J., de Steenwinkel, J. E. M., Burger, D. M., Aarnoutse, R. E., & Koenderink, J. B. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.08.004 · Cited by 50
Smits, A., Annaert, P., & Allegaert, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.035 · Cited by 50
Terada, T., & Hira, D. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1061-4 · Cited by 53
Chan, L., Lin, Y. S., Tay-Sontheimer, J., Trawick, D., Oelschlager, B. K., Flum, D. R., Patton, K. K., Shen, D. D., & Horn, J. R. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1560 · Cited by 54
Quan, E., Wang, H., Dong, D., Zhang, X., & Wu, B. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061598 · Cited by 50
Yu, J., Ritchie, T. K., Mulgaonkar, A., & Ragueneau, I. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060392 · Cited by 50
Effect of Cholesterol on Cellular Uptake of Cancer Drugs Pirarubicin and Ellipticine
Zhang, L., Bennett, W. F., Zheng, T., Ouyang, P.-K., Ouyang, X., Qiu, X., Luo, A., Karttunen, M., & Chen, P. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b12337 · Cited by 50
Self-citationScotcher, D., Jones, C., Posada, M. M., Rostami‐Hodjegan, A., & Galetin, A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9942-x · Cited by 50
Elsby, R., Chidlaw, S., Outteridge, S. N., Pickering, S., Radcliffe, A., Sullivan, R., Jones, H., & Butler, P. J. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.357 · Cited by 51
Antiparasitic, structural, pharmacokinetic, and toxicological properties of riparin derivatives
Mafud, A. C., Silva, M. P. N., Nunes, G. B. L., de Oliveira, M. A. R., Batista, L. F., Rubio, T. I., Mengarda, A. C., Lago, E. M., Xavier, R. P., Gutierrez, S. J. C., et al. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.012 · Cited by 50
Molecular and cellular physiology of organic cation transporter 2
Wright, S. H. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00422.2019 · Cited by 50
Self-citationDrug-Drug Interactions at Organic Cation Transporter 1
Zhou, S., Zeng, S., & Shu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.628705 · Cited by 55
Assessing donor-to-donor variability in human intestinal organoid cultures
Mohammadi, S., Morell-Perez, C., Wright, C. W., Wyche, T. P., White, C., Sana, T. R., & Lieberman, L. A. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.016 · Cited by 56
Wang, C., Preclaro, I. A. C., Lin, W.-H., & Chung, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.886377 · Cited by 64
Ganesh, A. N., Heusser, C., Garad, S., & Sánchez-Félix, M. V. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100079 · Cited by 50
Tian, M., Wu, S., Wang, Y., Liu, L., Zhang, J., Shen, H., Lu, Y.-Y., Bao, H., & Huang, Q. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129213 · Cited by 51
OAT, OATP, and MRP Drug Transporters and the Remote Sensing and Signaling Theory
Nigám, S. K., & Granados, J. C. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030322-084058 · Cited by 52
Prediction and validation of enzyme and transporter off-targets for metformin
Yee, S. W., Lin, L., Merski, M., Keiser, M. J., Gupta, A., Zhang, Y., Chien, H.-C., Shoichet, B. K., & Giacomini, K. M. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9436-y · Cited by 49
Self-citationPatik, I., Kovacsics, D., Német, O., Gera, M., Várady, G., Stieger, B., Hagenbuch, B., Szakács, G., & Özvegy‐Laczka, C. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.015 · Cited by 49
Polli, J. W., Hussey, E. K., Bush, M., Generaux, G. T., Smith, G. A., Collins, D., McMullen, S. L., Turner, N., & Nunez, D. J. (2012) · Xenobiotica · doi:10.3109/00498254.2012.739719 · Cited by 50
Self-citationJia, J., Puls, D., Oswald, S., Jedlitschky, G., Kühn, J., Weitschies, W., Hosten, N., Siegmund, W., & Keiser, M. (2013) · Investigative Radiology · doi:10.1097/rli.0b013e3182a70043 · Cited by 49
Novel strategies for microdose studies using non-radiolabeled compounds
Maeda, K., & Sugiyama, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.004 · Cited by 49
Self-citationGao, C., Zhang, H., Guo, Z., You, T., Chen, X., & Zhong, D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.047183 · Cited by 49
Kong, L., Zhuang, X., Yang, H., Yuan, M., Xu, L., & Li, H. (2015) · Scientific Reports · doi:10.1038/srep11747 · Cited by 49
Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Roth, A. D., & Lee, M. (2017) · BioMed Research International · doi:10.1155/2017/9176937 · Cited by 54
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.